BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 25945795)

  • 1. Mutations in RECQL Gene Are Associated with Predisposition to Breast Cancer.
    Sun J; Wang Y; Xia Y; Xu Y; Ouyang T; Li J; Wang T; Fan Z; Fan T; Lin B; Lou H; Xie Y
    PLoS Genet; 2015 May; 11(5):e1005228. PubMed ID: 25945795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RECQL: a new breast cancer susceptibility gene.
    Banerjee T; Brosh RM
    Cell Cycle; 2015; 14(22):3540-3. PubMed ID: 26125302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rare missense mutations in RECQL and POLG associate with inherited predisposition to breast cancer.
    Tervasmäki A; Mantere T; Hartikainen JM; Kauppila S; Lee HM; Koivuluoma S; Grip M; Karihtala P; Jukkola-Vuorinen A; Mannermaa A; Winqvist R; Pylkäs K
    Int J Cancer; 2018 Jun; 142(11):2286-2292. PubMed ID: 29341116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Germline RECQL mutations in high risk Chinese breast cancer patients.
    Kwong A; Shin VY; Cheuk IWY; Chen J; Au CH; Ho DN; Chan TL; Ma ESK; Akbari MR; Narod SA
    Breast Cancer Res Treat; 2016 Jun; 157(2):211-215. PubMed ID: 27125668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical implications of germline mutations in breast cancer genes: RECQL.
    Bowden AR; Tischkowitz M
    Breast Cancer Res Treat; 2019 Apr; 174(3):553-560. PubMed ID: 30610487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of a RECQL splicing mutation, c.1667_1667+3delAGTA, in breast cancer patients and controls from Central Europe.
    Bogdanova N; Pfeifer K; Schürmann P; Antonenkova N; Siggelkow W; Christiansen H; Hillemanns P; Park-Simon TW; Dörk T
    Fam Cancer; 2017 Apr; 16(2):181-186. PubMed ID: 27832498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Germline RECQL mutations are associated with breast cancer susceptibility.
    Cybulski C; Carrot-Zhang J; Kluźniak W; Rivera B; Kashyap A; Wokołorczyk D; Giroux S; Nadaf J; Hamel N; Zhang S; Huzarski T; Gronwald J; Byrski T; Szwiec M; Jakubowska A; Rudnicka H; Lener M; Masojć B; Tonin PN; Rousseau F; Górski B; Dębniak T; Majewski J; Lubiński J; Foulkes WD; Narod SA; Akbari MR
    Nat Genet; 2015 Jun; 47(6):643-6. PubMed ID: 25915596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FANCM and RECQL genetic variants and breast cancer susceptibility: relevance to South Poland and West Ukraine.
    Nguyen-Dumont T; Myszka A; Karpinski P; Sasiadek MM; Akopyan H; Hammet F; Tsimiklis H; Park DJ; Pope BJ; Slezak R; Kitsera N; Siekierzynska A; Southey MC
    BMC Med Genet; 2018 Jan; 19(1):12. PubMed ID: 29351780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RECQL: a DNA helicase in breast cancer.
    Akbari MR; Cybulski C
    Oncotarget; 2015 Sep; 6(29):26558-9. PubMed ID: 26387136
    [No Abstract]   [Full Text] [Related]  

  • 10. RECQ1 Helicase in Genomic Stability and Cancer.
    Debnath S; Sharma S
    Genes (Basel); 2020 Jun; 11(6):. PubMed ID: 32517021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RECQL5: Another DNA helicase potentially involved in hereditary breast cancer susceptibility.
    Tavera-Tapia A; de la Hoya M; Calvete O; Martin-Gimeno P; Fernández V; Macías JA; Alonso B; Pombo L; de Diego C; Alonso R; Pita G; Barroso A; Urioste M; Caldés T; Newman JA; Benítez J; Osorio A
    Hum Mutat; 2019 May; 40(5):566-577. PubMed ID: 30817846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel germline mutations in breast cancer susceptibility genes BRCA1, BRCA2 and p53 gene in breast cancer patients from India.
    Hedau S; Jain N; Husain SA; Mandal AK; Ray G; Shahid M; Kant R; Gupta V; Shukla NK; Deo SS; Das BC
    Breast Cancer Res Treat; 2004 Nov; 88(2):177-86. PubMed ID: 15564800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human RECQ Helicase Pathogenic Variants, Population Variation and "Missing" Diseases.
    Fu W; Ligabue A; Rogers KJ; Akey JM; Monnat RJ
    Hum Mutat; 2017 Feb; 38(2):193-203. PubMed ID: 27859906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RECON syndrome is a genome instability disorder caused by mutations in the DNA helicase RECQL1.
    Abu-Libdeh B; Jhujh SS; Dhar S; Sommers JA; Datta A; Longo GM; Grange LJ; Reynolds JJ; Cooke SL; McNee GS; Hollingworth R; Woodward BL; Ganesh AN; Smerdon SJ; Nicolae CM; Durlacher-Betzer K; Molho-Pessach V; Abu-Libdeh A; Meiner V; Moldovan GL; Roukos V; Harel T; Brosh RM; Stewart GS
    J Clin Invest; 2022 Mar; 132(5):. PubMed ID: 35025765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of RECQL germline variants in Pakistani early-onset and familial breast cancer patients.
    Rashid MU; Muhammad N; Khan FA; Shehzad U; Naeemi H; Malkani N; Hamann U
    Hered Cancer Clin Pract; 2020 Dec; 18(1):25. PubMed ID: 33342430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deleterious RAD51C germline mutations rarely predispose to breast and ovarian cancer in Pakistan.
    Rashid MU; Muhammad N; Faisal S; Amin A; Hamann U
    Breast Cancer Res Treat; 2014 Jun; 145(3):775-84. PubMed ID: 24800917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations in RECQL are not associated with breast cancer risk in an Australian population.
    Li N; Rowley SM; Goode DL; Amarasinghe KC; McInerny S; Devereux L; ; Wong-Brown MW; Lupat R; Lee JEA; Hughes S; Thompson ER; Zethoven M; Li J; Trainer AH; Gorringe KL; Scott RJ; James PA; Campbell IG
    Nat Genet; 2018 Oct; 50(10):1346-1348. PubMed ID: 30224651
    [No Abstract]   [Full Text] [Related]  

  • 18. RECQL, a member of the RecQ family of DNA helicases, suppresses chromosomal instability.
    Sharma S; Stumpo DJ; Balajee AS; Bock CB; Lansdorp PM; Brosh RM; Blackshear PJ
    Mol Cell Biol; 2007 Mar; 27(5):1784-94. PubMed ID: 17158923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune infiltration, aggressive pathology, and poor survival outcomes in RECQL helicase deficient breast cancers.
    Lashen A; Al-Kawaz A; Jeyapalan JN; Alqahtani S; Shoqafi A; Algethami M; Toss M; Green AR; Mongan NP; Sharma S; Akbari MR; Rakha EA; Madhusudan S
    Neoplasia; 2024 Jan; 47():100957. PubMed ID: 38134458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deleterious Germline BLM Mutations and the Risk for Early-onset Colorectal Cancer.
    de Voer RM; Hahn MM; Mensenkamp AR; Hoischen A; Gilissen C; Henkes A; Spruijt L; van Zelst-Stams WA; Kets CM; Verwiel ET; Nagtegaal ID; Schackert HK; van Kessel AG; Hoogerbrugge N; Ligtenberg MJ; Kuiper RP
    Sci Rep; 2015 Sep; 5():14060. PubMed ID: 26358404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.